Cancer News
Articles 131 - 140 of most recent articles
Researchers Identify Tumor Marker For Aggressive Thryoid Cancer
MicroRNA (miRNA) expression profiles can be used to identify an aggressive type of papillary thyroid cancer that is often otherwise difficult to detect, according to data to be presented on Oct. 2, 2008 at the 79th Annual Meeting of the American Thyroid Association (ATA) in Chicago, IL. miRNAs are a ... more »
Medical News Today – Oct 4, 2008 07:00 AM [GMT] – comment?
MicroRNA (miRNA) expression profiles can be used to identify an aggressive type of papillary thyroid cancer that is often otherwise difficult to detect, according to data to be presented on Oct. 2, 2008 at the 79th Annual Meeting of the American Thyroid Association (ATA) in Chicago, IL. miRNAs are a ... more »
Medical News Today – Oct 4, 2008 07:00 AM [GMT] – comment?
Program Offers Lifeline To Those Lost In The Transition From Cancer Patient To Cancer Survivor
At the end of her chemotherapy treatment for breast cancer, Sylvia Ott-Durkin of Schaumburg, Ill., found herself facing an unsettling quandary. "Finishing chemo was exciting but then I was confronted with the next step," said Ott-Durkin, a young mother of two. "My appointments were go ... more »
Medical News Today – Oct 4, 2008 07:00 AM [GMT] – comment?
At the end of her chemotherapy treatment for breast cancer, Sylvia Ott-Durkin of Schaumburg, Ill., found herself facing an unsettling quandary. "Finishing chemo was exciting but then I was confronted with the next step," said Ott-Durkin, a young mother of two. "My appointments were go ... more »
Medical News Today – Oct 4, 2008 07:00 AM [GMT] – comment?
Saliva Proteins May Help Spot Oral Cancer
HealthDay - FRIDAY, Oct. 3 (HealthDay News) -- A simple test of saliva proteins may one day help doctors detect oral cancer, according to a new study in the Oct. 1 issue of Clinical Cancer Research.
Yahoo! – Oct 4, 2008 05:47 AM [GMT] – comment?
HealthDay - FRIDAY, Oct. 3 (HealthDay News) -- A simple test of saliva proteins may one day help doctors detect oral cancer, according to a new study in the Oct. 1 issue of Clinical Cancer Research.
Yahoo! – Oct 4, 2008 05:47 AM [GMT] – comment?
Urine Samples Could Reveal Breast Cancer Risk
HealthDay - FRIDAY, Oct. 3 (HealthDay News) -- A simple urine test could oneday be an effective way to screen for breast cancer, a new studysuggests.
Yahoo! – Oct 4, 2008 03:46 AM [GMT] – comment?
HealthDay - FRIDAY, Oct. 3 (HealthDay News) -- A simple urine test could oneday be an effective way to screen for breast cancer, a new studysuggests.
Yahoo! – Oct 4, 2008 03:46 AM [GMT] – comment?
Millions to die in China from lung disease: reportReuters - Tens of millions of people will die from respiratory illness and lung cancer over the next 25 years in China if nothing is done to reduce smoking and fuel burning indoors, scientists warned.
Yahoo! – Oct 3, 2008 11:02 PM [GMT] – comment?
Genetic tests may pinpoint who should get Avastin
Reuters - Genetic tests could in future show who will respond best to Genentech and Roche's blockbuster cancer drug Avastin -- a positive development for patients but not necessarily for sales.
Yahoo! – Oct 3, 2008 3:30 PM [GMT] – comment?
Reuters - Genetic tests could in future show who will respond best to Genentech and Roche's blockbuster cancer drug Avastin -- a positive development for patients but not necessarily for sales.
Yahoo! – Oct 3, 2008 3:30 PM [GMT] – comment?
Health Services Research Finds Specialty Hospitals Not More Cost-Efficient Than Full-Service Hospitals
One of the most notable recent developments in the U.S. hospital industry is the rapid rise of small hospitals specializing in cardiac, orthopedic, or surgical services which have tripled in number over the past 15 years. A new study in Health Services Research compared the costs of physician-owned ... more »
Medical News Today – Oct 3, 2008 1:00 PM [GMT] – comment?
One of the most notable recent developments in the U.S. hospital industry is the rapid rise of small hospitals specializing in cardiac, orthopedic, or surgical services which have tripled in number over the past 15 years. A new study in Health Services Research compared the costs of physician-owned ... more »
Medical News Today – Oct 3, 2008 1:00 PM [GMT] – comment?
ORLive Presents: IntraBeam(R): Intraoperative Radiation Treatment In Early Stage Breast Cancer
Join the live lumpectomy surgery to remove early stage breast cancer and prepare the surgical site for IntraBeam(R), intraoperative radiation therapy that occurs right in the operating room. From Sentara CarePlex Hospital in Hampton, Virginia with surgical oncologist Dr. Richard C. Hoefer and radiat ... more »
Medical News Today – Oct 3, 2008 12:00 PM [GMT] – comment?
Join the live lumpectomy surgery to remove early stage breast cancer and prepare the surgical site for IntraBeam(R), intraoperative radiation therapy that occurs right in the operating room. From Sentara CarePlex Hospital in Hampton, Virginia with surgical oncologist Dr. Richard C. Hoefer and radiat ... more »
Medical News Today – Oct 3, 2008 12:00 PM [GMT] – comment?
Developing GA101, A Humanized Anti-CD20 Monoclonal Antibody With Hematological Malignancies Potential Treatment - Genentech, GlycArt And Roche Collabo
Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt's GA101 molecule.
Medical News Today – Oct 3, 2008 12:00 PM [GMT] – comment?
Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt's GA101 molecule.
Medical News Today – Oct 3, 2008 12:00 PM [GMT] – comment?
Merck KGaA: Survival In 1st-Line Non-Small Cell Lung Cancer
Data presented today at the 1st International Thoracic Oncology Congress Dresden (ITOCD) demonstrate that the addition of Erbitux® (cetuximab) to standard platinum-based chemotherapy in the 1st-line treatment of advanced NSCLC resulted in a significantly longer overall survival. The patient pop ... more »
Medical News Today – Oct 3, 2008 11:00 AM [GMT] – comment?
Data presented today at the 1st International Thoracic Oncology Congress Dresden (ITOCD) demonstrate that the addition of Erbitux® (cetuximab) to standard platinum-based chemotherapy in the 1st-line treatment of advanced NSCLC resulted in a significantly longer overall survival. The patient pop ... more »
Medical News Today – Oct 3, 2008 11:00 AM [GMT] – comment?
More Health News
